An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...
At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...
This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...
In other words, raising pay for doctors could lead to more sustainable health costs in the long run. It could also attract ...
A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not ...
Prior authorization reforms, increased biosimilar access and the future of the Medicare drug price negotiation program are ...
It’s unsustainable. Congress needs to Fix Medicare Now, connect Medicare pay to inflation, and help doctors keep their practices open to ensure access for Medicare patients in the future.” ...
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading into a federal court case over abortion access ...